The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | N | Nervous system | |
2 | N03 | Antiepileptics | |
3 | N03A | Antiepileptics | |
4 | N03AB | Hydantoin derivatives |
Code | Title | |
---|---|---|
N03AB01 | Ethotoin | |
N03AB02 | Phenytoin | |
N03AB03 | Amino(diphenylhydantoin) valeric acid | |
N03AB04 | Mephenytoin | |
N03AB05 | Fosphenytoin | |
N03AB52 | Phenytoin, combinations | |
N03AB54 | Mephenytoin, combinations |
Active Ingredient | Description | |
---|---|---|
Ethotoin |
Ethotoin is a hydantoin anticonvulsant with anti-epileptic activity. Ethotoin exerts an antiepileptic effect without causing general central nervous system depression. The mechanism of action is probably very similar to that of phenytoin. |
|
Phenytoin |
Phenytoin is effective in various animal models of generalised convulsive disorders, reasonably effective in models of partial seizures but relatively ineffective in models of myoclonic seizures. It appears to stabilise rather than raise the seizure threshold and prevents spread of seizure activity rather than abolish the primary focus of seizure discharge. |
Title | Information Source | Document Type | |
---|---|---|---|
CEREBYX Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
DILANTIN Extended-release capsule | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
DILANTIN INFATABS Chewable tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
DILANTIN-125 Oral suspension | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
EPANUTIN Oral suspension | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
EPANUTIN READY MIXED Solution for injection or infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
PRO-EPANUTIN Concentrate for solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |